This appeal arises from a qui tam action filed by Steven M. Camburn, a former Novartis sales executive, on behalf of the United States, twenty-nine states, the District of Columbia, and two cities. Camburn alleged that Novartis Pharmaceuticals Corporation violated the False Claims Act by offering remuneration to physicians to induce them to prescribe its multiple sclerosis drug, Gilenya, in violation of the federal Anti-Kickback Statute. The case centered on Novartis's peer-to-peer speaker program, which Camburn claimed was a pretext for illicit payments. The district court had dismissed the operative Third Amended Complaint with prejudice, ruling that Camburn failed to plead the existence of a kickback scheme with the particularity required by Federal Rule of Civil Procedure 9(b).
The Second Circuit addressed two primary legal issues: the standard for pleading an Anti-Kickback Statute violation and the sufficiency of Camburn's specific factual allegations. First, the court held as a matter of first impression in the Circuit that a plaintiff states an AKS violation if they allege with requisite particularity that at least one purpose of the scheme was to induce fraudulent conduct. This 'at-least-one-purpose' rule does not require a plaintiff to prove a direct quid pro quo exchange or that inducing fraud was the sole purpose of the payment. Second, applying this rule and the heightened pleading standard of Rule 9(b), the court conducted a case-specific inquiry. The court found that Camburn adequately pleaded three categories of facts that gave rise to a strong inference of fraud: (1) speaker events held with no legitimate attendees, such as lavish dinners where only Novartis staff or colleagues attended; (2) excessive compensation paid to physicians for events that were canceled; and (3) the deliberate selection and retention of speakers to reward high-prescribing physicians. Conversely, the court affirmed the dismissal of other allegations, including those regarding DVD initiatives, entertainment rooms, and one-on-one dinners, concluding that these facts, without more, failed to nudge the claims from conceivable to plausible under the Rule 9(b) standard.
The judgment is partially affirmed and partially vacated and remanded. The case will proceed in the district court only on the three specific categories of allegations regarding sham speaker events, canceled event compensation, and speaker selection for prescription incentives. All other claims are dismissed. The district court is instructed to evaluate whether these remaining allegations satisfy all elements of a False Claims Act claim and to assess any applicable state or municipal law claims consistent with this opinion.
Podcast (federal-narrative-summaries): Play in new window | Download